Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme—a retrospective cohort study

Overview of attention for article published in Frontiers in immunology, July 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 32,846 followers.

RT @FrontImmunol: New Research: Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme—a retrospective cohort st…

18 Jul 2023

Reply Repost Favourite

New Research: Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme—a retrospective cohort study: Background and objectives Glioblastoma multiforme (GBM) is the most aggressive, malignant, and therapy-resistant… #immunology htt

17 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.